PET-CT confirmed complete remission and MRD negativity in mantle cell lymphoma patients treated with R-hyper-CVAD results in excellent outcome in the absence of autologous stem cell transplantation: a single-centre case for a transplant-free approach

Intern Med J. 2016 Sep;46(9):1113-4. doi: 10.1111/imj.13179.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Dexamethasone / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Lymphoma, Mantle-Cell / diagnostic imaging*
  • Lymphoma, Mantle-Cell / drug therapy*
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Remission Induction
  • Retrospective Studies
  • Transplantation, Autologous
  • Vincristine / therapeutic use

Substances

  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide

Supplementary concepts

  • CVAD protocol